Category: Value in Health Regional Issues

Scientific journal of the International Society for Pharmacoeconomics and Outcomes Research (ISPOR) published up to three times a year with one issue focusing on the Asian region, one issue focusing on the Latin American region, and one issue focusing on the Central & Eastern Europe, Western Asia and African region.

ISPOR’s VALUE IN HEALTH REGIONAL ISSUES ACCEPTED FOR INDEXING IN MEDLINE®/PUBMED®

Princeton, NJ—December 6, 2016—The International Society for Pharmacoeconomics and Outcomes Research (ISPOR) announced that its regional health economics and outcomes research (HEOR) publication, Value in Health Regional Issues, was recently accepted for indexing in MEDLINE®/PubMed®.

Posted in Announcements, ISPOR Journals, ISPOR News & Press, Value in Health Regional Issues Tagged with: , ,

ISPOR RECOGNIZES 2016 AWARDS PROGRAM RECIPIENTS AT 21ST ANNUAL INTERNATIONAL MEETING

AWARDS RECOGNIZE EXCELLENCE IN HEOR Washington, DC—May 24, 2016—The International Society for Pharmacoeconomics and Outcomes Research (ISPOR) recognized its 2016 ISPOR Awards Program recipients at the 21st Annual International Meeting in Washington, DC, USA. The ISPOR Awards Program is designed

Posted in Announcements, ISPOR Journals, ISPOR News & Press, Value in Health, Value in Health Regional Issues Tagged with: , , ,

ISPOR ANNOUNCES 2016 SCIENTIFIC ACHIEVEMENT AWARDS

Princeton, NJ—March 30, 2016—The International Society for Pharmacoeconomics and Outcomes Research (ISPOR) announced today the recipients of its 2016 Scientific Achievement Awards.

Posted in Announcements, ISPOR Journals, ISPOR News & Press, Value in Health, Value in Health Regional Issues Tagged with: , , , , ,

COST OF DIABETES MELLITUS – IS EARLY DIAGNOSIS A SAVIOR?

Accra, Ghana – The number of diabetes cases and the associated health care budget has been increasing worldwide. It has thus become a growing public health burden for patients, health care providers, and society. The cost of diabetes study has

Posted in Health Policy Analyses, ISPOR News & Press, Value in Health Regional Issues Tagged with: , , , , ,

GENERATING EQ-5D-5L HEALTH STATE VALUES IN THE UAE

Abu Dhabi, UAE – Evidence on the health-related quality of life of patients is increasingly being requested by payers in the Middle East. Yet, no EQ-5D-5L value sets are currently available to inform decision making in the region’s health care

Posted in ISPOR News & Press, Preference-Based Assessments, Value in Health Regional Issues Tagged with:

DECONSTRUCTING PHARMACEUTICAL TENDERING: UNDERSTANDING THE UNDERLYING ELEMENTS

Latsia, Cyprus – Tendering is an aggressive pricing and reimbursement tool with proven potency in the pharmaceutical sector.  The pharmaceutical sector is exhibiting high annual sales-increase rates; therefore, the need for optimized, potent, and sustainable pricing and reimbursement tools is

Posted in Health Policy Analyses, ISPOR News & Press, Value in Health Regional Issues Tagged with: , , , , , ,

IS PAYERS’ DATABASE SUITABLE FOR CANCER SERVICE EVALUATION?

Budapest, Hungary – Malignant diseases represent a high burden for societies in Central and Eastern European countries. The data routinely collected in the database of the Hungarian National Health Insurance Fund can be used to assess some quality indicators related

Posted in Health Policy Analyses, ISPOR News & Press, Value in Health Regional Issues Tagged with: , ,

THE FOURTH HURDLE – CAN IT BE SIMPLIFIED?

Melbourne, Australia – While regulatory systems are well established within Asia-Pacific countries, formalised health technology assessment (HTA) based reimbursement systems are relatively new, yet rapidly evolving. Closer understanding of the different reimbursement processes within Asia-Pacific can allow for best-practice cross-pollination, leading

Posted in Health Policy Analyses, Value in Health Regional Issues Tagged with: , , ,